Fischer Medical Ventures working capital

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026
32.42×32.42×
341.61×341.61×
262.67×262.67×
111.36×111.36×
2.30×1.93×
0.46×0.46×
−3.26×−3.26×
−2.35×−2.35×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FISCHER₹25.93

Fischer Medical Ventures Limited

· Pharma & Health
₹ CrorePeersTARSONSLAXMIDENTLFABTECHGKBMcap ₹1,697 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)32.4232.42
Receivable Days (DSO)341.61341.61
Payable Days (DPO)262.67262.67
Cash Conversion Cycle (days)111.36111.36
Working Capital Turnover1.932.30
Asset Turnover0.460.46
Cash Conversion (CFO/Net Income)-3.26-3.26
CFO/EBITDA-2.35-2.35
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.